Floatz logo

Therapeutic Asset Ratings

168 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Fludarabine
Recurrent Adult Immunoblastic Large Cell Lymphoma
Essen BiotechP2BBB (76)
Cyclophosphamide
Recurrent Adult Immunoblastic Large Cell Lymphoma
Essen BiotechP3BBB (72)
Cyclophosphamide
Sarcoma
Essen BiotechP2BB (68)
Cyclophosphamide
Brain Tumor
Essen BiotechP3BB (67)
Pembrolizumab
Metastatic Pancreatic Cancer
Essen BiotechP2/3BB (67)
Pembrolizumab
Bladder Cancer
Essen BiotechP3BB (66)
Pembrolizumab
Pancreas Cancer
Essen BiotechP2BB (66)
Pembrolizumab
Kidney Cancer
Essen BiotechP4BB (65)
Epirubicin
Brain Tumor
Essen BiotechP3BB (65)
Pembrolizumab
Brain Tumor
Essen BiotechP3BB (65)
Cyclophosphamide
Brain Cancer
Essen BiotechP2BB (65)
Pembrolizumab
Non-Melanoma Skin Cancer
Essen BiotechP2BB (65)
Cyclophosphamide
Bone Sarcoma
Essen BiotechP2BB (64)
Cyclophosphamide
Meningioma
Essen BiotechP2B (63)
Cyclophosphamide
Rectum Cancer
Essen BiotechP2B (63)
Pembrolizumab
Sarcoma
Essen BiotechP2B (63)
Pembrolizumab
Esophageal Cancer
Essen BiotechP3B (62)
Fludarabine
Meningioma
Essen BiotechP2B (62)
Pembrolizumab
Advanced Lung Carcinoma
Essen BiotechP2B (62)
Cyclophosphamide
Colon Cancer
Essen BiotechP2B (61)
Cyclophosphamide
Ewing Sarcoma
Essen BiotechP2B (61)
Cyclophosphamide
Pancreatic Carcinoma
Essen BiotechP2B (61)
Cyclophosphamide
Glioma
Essen BiotechP2B (60)
Epirubicin
Brain Cancer
Essen BiotechP2B (60)
Epirubicin
Rectum Cancer
Essen BiotechP2B (60)
Showing 1 to 25 of 168 assets
PreviousPage 1 of 7Next